CEACAM5 has been widely studied in various kinds of cancers, including breast cancer [27], colorectal cancer [28, 29], pancreatic cancer [30], gastric cancer [31], and carcinoma of the tongue [32]. This evidence concerns the gene CEACAM5 and gastric cancer.